Minor salivary gland biopsy: Its role in the classification and prognosis of Sjögren's syndrome

Autoimmun Rev. 2020 Dec;19(12):102690. doi: 10.1016/j.autrev.2020.102690. Epub 2020 Oct 22.

Abstract

Sjögren's syndrome (SS) is an autoimmune disorder characterized by mononuclear cell infiltration in the exocrine glands, which leads to sicca syndrome (xerostomia and xerophthalmia). The etiology of SS is unknown, but multiple environmental factors (infectious, hormonal and stress-related), as well as genetic factors, may play a role in its pathogenesis. The diagnosis of SS is complex considering its clinical and paraclinical parameters may not be very specific. The minor salivary gland biopsy (MSGB) has undoubtedly become crucial for classifying and determining the prognosis of SS. The three main different classification systems for its interpretation have been described by Chisholm and Mason, Greenspan and Daniels, and Tarpley. However, this invasive procedure has variable sensitivity and specificity as well as low reproducibility. The use of additional methods, such as skin biopsy, imaging techniques, and serum/salivary biomarkers, may be combined with current methods to develop a bioscore that could increase diagnostic performance. In this review, we summarized the main pathological findings in SS and the prognosis of patients with SS according to the biopsy results.

Keywords: Chisholm and Mason; Focus score; Greenspan and Daniels; Minor salivary gland biopsy; Sjögren's syndrome; Tarpley.

Publication types

  • Review

MeSH terms

  • Biopsy
  • Humans
  • Prognosis
  • Reproducibility of Results
  • Salivary Glands, Minor* / pathology
  • Sjogren's Syndrome* / diagnosis